Every compound REVYA distributes is held to a defined verification standard before it is released. We don’t ask researchers
to take our word for it — our model is built on documentation, independent testing, and transparency at the batch level.

For research use only. Not for human or animal consumption. Not for therapeutic, diagnostic, or clinical use. These products have not
been evaluated or approved by the FDA.

 

01. Independent U.S. Laboratory Verification

Every batch will be independently verified through U.S.-based analytical laboratories prior to release. We do not rely on overseas testing or
reuse manufacturer-supplied reports. Each lot is tested on its own merits, in the United States, before it reaches a researcher.

02. Purity Standard

Our specification is ≥98% purity, confirmed by HPLC or LC-MS analysis. Purity, identity, and consistency are verified for each lot rather than
assumed from a manufacturer’s specification sheet.

03. Lot Traceability & Certificates of Analysis

Every batch is assigned a lot number tied to its own Certificate of Analysis (COA). The batch-specific COA will be published and available for
review prior to release, so the document you rely on corresponds to the exact material in hand — not a representative sample from a different
lot.

04. U.S.-Based Fulfillment & Quality Control

Fulfillment and quality control are handled through U.S.-based infrastructure, with a structured process governing how each batch is received,
verified, documented, and released.

05. Compliance-First Framework

REVYA operates within a compliance-first framework: structured labeling standards, clear research-use-only designation, and documentation
practices designed to meet the expectations of a professional research supply chain. We source from vetted manufacturers and treat
regulatory discipline as a core operating standard, not an afterthought.